Research Platform
Agentic Drug Design
Agentic Drug Design
Powered by Evolution
Combining 100 million years of mammalian selection pressure with AI-driven molecular optimization. Autonomous discovery, from target to therapeutic.
Development Active
Evolution-Guided Targets
Leverage dN/dS ratios from 190 mammalian species to identify evolutionarily constrained druggable surfaces.
Multi-Agent Architecture
Designer, Critic, and Validator agents collaborate through structured debate to reduce hallucinations and optimize candidates.
Simulation-First
90,000+ peptides/second throughput. Validate agent workflows in simulation before connecting real chemistry tools.
The Evolution² Pipeline
EvoSeed
Generate diverse peptide libraries
EvoQC
8-filter quality control
EvoBreed
Genetic optimization
EvoSurrogate
Neural scoring
EvoSim
MD validation
190
Mammalian Species (EvoArray)
90K+
Peptides/Second
8
QC Filters
23
Agent Tools